Top 10 AI News Updates Trending on Wall Street

7. Tevogen Bio Holdings Inc. (NASDAQ:TVGN)

Number of Hedge Fund Holders: 10

Tevogen Bio Holdings Inc. (NASDAQ:TVGN) is a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T-cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company is increasingly attracting interest, this time from the Center for the Biomedical Advanced Research and Development Authority (BARDA). On February 7th, the company held discussions with BARDA, focusing on the game-changing ExacTcell technology as a potential medical countermeasure.

Tevogen Bio Holdings Inc.’s (NASDAQ:TVGN) scalable and reasonably priced ExacTcell platform, the encouraging outcomes of TVGN 489’s proof-of-concept clinical trial, and the incorporation of Artificial intelligence into their production procedures were the three main topics of discussion. The conversation focused on how ExacTcell can quickly adjust to new viral threats, making it a viable option for protecting the public’s health. The company has already opened talks with federal agencies as it looks to tap opportunities around its AI innovations.